Kratos (KTOS) 2025 Earnings Outlook: Growth, Risks
Investors are eyeing kratos (ktos) 2025 earnings as defense programs underpin revenue. This guide breaks down what to...
Value Weighted Index Funds Fees 2024
Value Weighted Index Funds Fees 2024 reveal how expense structures shape long-term results. This quick intro explains what to compare and how to pick affordable options.
23,499 articles
Three Charts Highlight Affordability Issues in 2026
New data released this week shows Americans facing persistent affordability pressures. Three charts highlight afforda...
Lowe’s Stumbles on Weak Guidance as TJX Climbs on Beat
Lowe’s beat on near-term earnings but issued a muted FY26 outlook, sending its stock lower while TJX jumped on strong...
Krispy Kreme’s Sales Fell, Yet Stock Bets a Turnaround
Krispy Kreme’s stock jumped after a quarterly report showed potential signs of a turnaround, even as revenue declined...
Only Have Until March: Make This Medicare Move Now
Retirement planning isn’t only about investments. Health coverage decisions during the March window can affect your c...
President Trump's Nomination of Kevin Warsh and Markets
A potential shift at the Fed could ripple through stocks, bonds, and a retiree's paycheck. This in-depth look examine...
Live: Will Credo Technology Deliver After the Bell Tonight
Credo Technology is set to report after the close, with investors watching margins and guidance as the stock prices i...
Live: Will CrowdStrike Beat Q4 Earnings Tonight? Stakes Rise
CrowdStrike is set to report Q4 results after the close, with analysts predicting a beat on non-GAAP earnings and rev...
Buffett’s Stake Giving Investors Confidence in OXY Stock
Occidental Petroleum uses $9.7B from the OxyChem sale to trim debt, boosting cash flow and dividends. Berkshire Hatha...
IGV Bounces 5% as SaaS Selloff May Still Be Over
IGV climbed roughly 5% over the past week, defying a broader tech pullback. Yet traders remain split on whether the A...
Does This Flag Kroger’s Dividend Aristocrat Status Risk?
Kroger reports fiscal 2025 results with a GAAP payout surge caused by a major impairment, yet cash flow and 2026 earn...
Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status